Anders D. Hove, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 90,000 shares at $24.98 ($2.2M) on 2014-09-12, disclosed to the SEC on 2014-09-16.
Scheduled sale ($2.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.98 | 15,000 | $375K | 16.7% |
| 2 | $24.99 | 75,000 | $1.9M | 83.3% |
| Total | $24.99 avg | 90,000 | $2.2M | 100% |
| Filing → |
| ANAC | SELL | 2015-12-17 | $100.1M | — | Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |
| ANAC | SELL | 2015-11-12 | $10.4M | — | Filing → |